Skip to main content

Icon

ICON PLC is a global clinical research organization providing outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The company offers clinical trial management, drug development strategy, laboratory testing, regulatory consulting, and post-market surveillance capabilities. Revenue is principally generated through service contracts covering phase one through four clinical trials and specialized clinical research support. Its end markets consist of global pharmaceutical corporations, biotechnology startups, and medical device developers seeking operational expertise for clinical testing. As one of the largest contract research organizations globally, ICON holds a major market position in international biopharmaceutical development services. The company is headquartered in Dublin, Ireland, and its ordinary shares are publicly traded on the Nasdaq Stock Market.

10 of the funds FundTelligence covers report a position in Icon.

Legal name
ICON PLC
Sector
Health Care
Country
Ireland
Funds holding it
10

Funds holding Icon

Showing the 8 largest of 10 funds holding it.

Loading...